logo
Select company
Select metric
Ticker Information

Ticker

ZYME

Company Name

ZYMEWORKS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZYMEWORKS INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZYME - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ -67.42M$ 834.45M0
3/31/2025$ -107.17M$ 731.05M0
12/31/2024$ -116.61M$ 869.4M0
9/30/2024$ -118.02M$ 841.48M0
6/30/2024$ -115.98M$ 667.36M0
3/31/2024$ -127.86M$ 546.66M0
12/31/2023$ -119.24M$ 732.12M0
9/30/2023$ 220.4M$ 447.83M2.03
6/30/2023$ 200.1M$ 411.37M2.06
3/31/2023$ 184.97M$ 407.78M2.2
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZYMEWORKS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, ZYMEWORKS INC's average EV/EBIT has been 1.83.
  • The median EV/EBIT for ZYMEWORKS INC during this period was 2.04
  • ZYMEWORKS INC reached its highest EV/EBIT over the past 5 years at 2.2.
  • The lowest EV/EBIT recorded by ZYMEWORKS INC in the same timeframe 1.01

ZYMEWORKS INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
CRMD : CORMEDIX INC 12.53NAGE : NIAGEN BIOSCIENCE INC 37.78URGN : UROGEN PHARMA LTD -ANAB : ANAPTYSBIO INC -PHAT : PHATHOM PHARMACEUTICALS INC -GERN : GERON CORP -SNDX : SYNDAX PHARMACEUTICALS INC -NRIX : NURIX THERAPEUTICS INC -GYRE : GYRE THERAPEUTICS INC 91.92XNCR : XENCOR INC -

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for ZYMEWORKS INC is calculated as follows: EV [ $ 1.6B ] / EBIT [ $ -215.23M ]
(=) EV/EBIT [ 0 ]

ZYME - Enterprise Value over EBIT, Last 5 years

1.01

Minimum

Dec 31, 2022

2.2

Maximum

Mar 31, 2023

1.83

Average

2.04

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32